Preliminary IFRS result for third quarter of 2019: NAV per share at EUR 5.60 still well above current stock level

Berlin, October 29, 2019: MPH Health Care AG (ISIN: DE000A0L1H32) announces preliminary IFRS results for the third quarter of 2019. The equity of the investment company amounted to EUR 239.57 million as of September 30, 2019 (previous year: EUR 281.00 million). The net asset value (NAV) per share was Euro 5.60 (previous year: Euro 6.56) and thus still well above the current price level (Xetra closing price 28 October 2019: Euro 3,72).

The decline in the share price of HAEMATO AG from EUR 4.65 per share (31.12.2018) to EUR 3.01 per share on 30.09.2019 in particular led to a decline in the NAV. HAEMATO AG has taken extensive measures to increase earnings (e.g. streamlining the product portfolio) and is currently in the process of establishing new personnel and digital structures in the product management, procurement and sales divisions.

"We are confident about the further development of our listed investments HAEMATO AG, M1 Kliniken AG and CR Capital Real Estate AG despite the short-term decline in the share price. M1 and CR in particular are developing very positively in operational terms and HAEMATO is currently implementing important measures to increase earnings," says Patrick Brenske, member of the Management Board of MPH.

About MPH Health Care AG:

MPH AG is an investment company with a strategic focus on the acquisition, development and sale of companies and company shares, particularly in growth segments of the healthcare market. This includes both insurance-financed and privately financed segments. MPH also exploits potential in high-growth and high-yield sectors outside the healthcare market. MPH Health Care AG shares are listed on the Frankfurt Stock Exchange. Further information: -ag.de

Key figures for the MPH Health Care AG share:

Subscribed Capital: EUR 42,813,842
Listed class of shares: Bearer ordinary shares
ISIN: DE000A0L1H32
WKN: A0L1H3
Ticker symbol: 93M